학술논문

Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Document Type
Article
Source
In: Arthritis and Rheumatology. (Arthritis and Rheumatology, November 2023, 75(11):1983-1993)
Subject
Language
English
ISSN
23265205
23265191